Deceptive statements on the way to revenue. Look at OPT. Certain Phase 3 trials failed.
RCE has a long way to go before $$. Shocking management. IMO
Ann: Placement and Entitlement Offer to Fund Phase III Trials, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
-0.010(3.08%) |
Mkt cap ! $90.83M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 33.0¢ | 30.5¢ | $40.79K | 129.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 21894 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 34332 | 2 |
View Market Depth
| Last trade - 13.46pm 18/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |